The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Concise Synthesis of Fostriecin and Analogs through Late-Stage Chemoenzymatic Installation of Their Key Pharmacophores
Open accessPublished version of a preprint
Abstract
As one of the most potent and selective protein phosphatase inhibitors, fostriecin shows a broad range of anticancer activity. In light of fostriecin’s antiproliferative properties, a phase I clinical trial was conducted on the natural product, but was soon halted due to issues with compound stability and purity. Numerous efforts in the past two decades have yielded 17 successful syntheses that proceed in 19 to 34 steps. Herein, we develop a modular chemoenzymatic approach that provides fostriecin and its analogs in a collective manner in 9 steps (longest linear sequence). The synthesis features a convergent assembly of three key fragments and a late-stage chemoenzymatic derivatization of an advanced intermediate that (i) installs two of the key pharmacophores and (ii) allows ready diversification of the hydrophobic tail. A key feature in this derivatization is the optimization of an enzymatic C–H oxidation step through the concurrent use of decoy molecule strategy and rational enzyme engineering. Cumulatively, our strategy capitalizes on the exquisite chemoselectivity of enzymatic transformations while ensuring synthetic modularity and versatility for analog generation. This work will facilitate future investigation into the biological activities and medicinal chemistry of the natural product family.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
Varadi, M., Bertoni, D., Magana, P., Paramval, U., Pidruchna, I., Radhakrishnan, M., Tsenkov, M., Nair, S., Mirdita, M., Yeo, J., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkad1011 · Cited by 2,052
Relative Reaction Rates of Olefin Substrates with Ruthenium(II) Carbene Metathesis Initiators1
Ulman, M., & Grubbs, R. H. (1998) · Organometallics · doi:10.1021/om9710172 · Cited by 222
Walsh, A. H., Cheng, A., & Honkanen, R. E. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01210-6 · Cited by 215
Increased Efficiency in Cross-Metathesis Reactions of Sterically Hindered Olefins
Stewart, I. C., Douglas, C. J., & Grubbs, R. H. (2008) · Organic Letters · doi:10.1021/ol702624n · Cited by 175
Sato, M., Miyaura, N., & Suzuki, A. (1989) · Chemistry Letters · doi:10.1246/cl.1989.1405 · Cited by 166
Tuning a P450 Enzyme for Methane Oxidation
Zilly, F. E., Acevedo, J. P., Augustyniak, W., Deege, A., Häusig, U. W., & Reetz, M. T. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201006587 · Cited by 163
Kawakami, N., Shoji, O., & Watanabe, Y. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201007975 · Cited by 144
Fostriecin: Chemistry and Biology
Lewy, D. S., Gauss, C.-M., Soenen, D. R., et al. (2002) · Current Medicinal Chemistry · doi:10.2174/0929867023368809 · Cited by 142
Moore, L. R., & Shaughnessy, K. H. (2003) · Organic Letters · doi:10.1021/ol0360288 · Cited by 135
Li, S., Podust, L. M., & Sherman, D. H. (2007) · Journal of the American Chemical Society · doi:10.1021/ja075842d · Cited by 122
Inhibition of type II topoisomerase by fostriecin
Boritzki, T. J., Wolfard, T. S., Besserer, J. A., Jackson, R., & Fry, D. W. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90096-2 · Cited by 118
Novel antitumor agents CI-920,PD113,270 and PD113,271. II. Isolation and characterization.
STAMPWALA, S. S., Bunge, R. H., Hurley, T. R., WILLMER, N. E., BRANKIEWICZ, A. J., STEINMAN, C. E., Smitka, T. A., & FRENCH, J. C. (1983) · The Journal of Antibiotics · doi:10.7164/antibiotics.36.1601 · Cited by 114
Wynn, D. A. (1984) · Talanta · doi:10.1016/0039-9140(84)80244-1 · Cited by 112
Tunac, J. B., GRAHAM, B. D., & Dobson, W. E. (1983) · The Journal of Antibiotics · doi:10.7164/antibiotics.36.1595 · Cited by 103
Hastie, C. J., & Cohen, P. T. W. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00775-3 · Cited by 101
Weinbrenner, C., Baines, C. P., Liu, G.-S., Armstrong, S. C., Ganote, C. E., Walsh, A. H., Honkanen, R. E., Cohen, M. V., & Downey, J. M. (1998) · Circulation · doi:10.1161/01.cir.98.9.899 · Cited by 82
Bialy, L., & Waldmann, H. (2004) · Chemistry - A European Journal · doi:10.1002/chem.200305543 · Cited by 73
Further improvement of phosphite dehydrogenase thermostability by saturation mutagenesis
McLachlan, M. J., Johannes, T. W., & Zhao, H. (2007) · Biotechnology and Bioengineering · doi:10.1002/bit.21546 · Cited by 73
Hoveyda, A. H., Liu, Z., Qin, C., Koengeter, T., & Mu, Y. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202010205 · Cited by 69
Swingle, M. R., Amable, L., Lawhorn, B. G., Buck, S. B., Burke, C. P., Ratti, P., Fischer, K. L., Boger, D. L., & Honkanen, R. E. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.155630 · Cited by 61
Determination of the Relative and Absolute Stereochemistry of Fostriecin (CI-920)
Boger, D. L., Hikota, M., & Lewis, B. M. (1997) · The Journal of Organic Chemistry · doi:10.1021/jo962166h · Cited by 59
Kuang, C., Yang, Q., Senboku, H., & Tokuda, M. (2005) · Tetrahedron · doi:10.1016/j.tet.2005.02.043 · Cited by 56
Phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecin
de Jong, R. S., Mulder, N. H., Uges, D. R. A., Sleijfer, D. T., Höppener, F., Groen, H. J. M., Willemse, P. H. B., van der Graaf, W. T. A., & de Vries, E. G. E. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690141 · Cited by 55
Scheithauer, W., Hoff, D. D. V., Clark, G. M., Shillis, J. L., & Elslager, E. F. (1986) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(86)90057-x · Cited by 54
Synthetic Strategies Employed for the Construction of Fostriecin and Related Natural Products
Trost, B. M., Knopf, J. D., & Brindle, C. S. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00488 · Cited by 50
A facile two-step synthesis of 8-arylated guanosine mono- and triphosphates (8-aryl GXPs)
Collier, A., & Wagner, G. K. (2006) · Organic & Biomolecular Chemistry · doi:10.1039/b614477b · Cited by 49
The biochemical pharmacology of CI-920, a structurally novel antibiotic with antileukemic activity
Jackson, R., Fry, D. W., Boritzki, T. J., Roberts, B. J., Hook, K. E., & Leopold, W. R. (1985) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(85)90048-2 · Cited by 44
de Jong, R. S., de Vries, E., & Mulder, N. H. (1997) · Anti-Cancer Drugs · doi:10.1097/00001813-199706000-00001 · Cited by 43
Armstrong, S., Gao, W., Lane, J., & Ganote, C. E. (1998) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1997.0572 · Cited by 40
Le, L., Erlichman, C., Pillon, L., Thiessen, J. J., Day, A., Wainman, N., Eisenhauer, E. A., & Moore, M. J. (2004) · Investigational New Drugs · doi:10.1023/b:drug.0000011792.13160.b0 · Cited by 40
Solvent Effects on the Selectivity of Palladium‐Catalyzed Suzuki‐Miyaura Couplings
Reeves, E. K., Bauman, O. R., Mitchem, G. B., & Neufeldt, S. R. (2019) · Israel Journal of Chemistry · doi:10.1002/ijch.201900082 · Cited by 40
Modular chemoenzymatic synthesis of ten fusicoccane diterpenoids
Jiang, Y., & Renata, H. (2024) · Nature Chemistry · doi:10.1038/s41557-024-01533-w · Cited by 38
Self-citationSabitha, G., Fatima, N., Gopal, P., Reddy, C. N., & Yadav, J. S. (2009) · Tetrahedron Asymmetry · doi:10.1016/j.tetasy.2008.12.004 · Cited by 37
Structural studies of tris(dialkylamino) sulfonium (TAS) fluorosilicates
Dixon, D. A., Farnham, W. B., Heilemann, W., Mews, R., & Noltemeyer, M. (1993) · Heteroatom Chemistry · doi:10.1002/hc.520040225 · Cited by 34
Kong, R., Liu, X., Su, C., Ma, C., Qiu, R., & Tang, L. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.10.018 · Cited by 33
Di, S., Fan, S., Jiang, F., & Cong, Z. (2022) · Antioxidants · doi:10.3390/antiox11030529 · Cited by 25
Goldring, W., Pattenden, G., & Rimmington, S. L. (2009) · Tetrahedron · doi:10.1016/j.tet.2009.04.021 · Cited by 21
Della‐Felice, F., Sarotti, A. M., Krische, M. J., & Pilli, R. A. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b07512 · Cited by 19
Synthesis and Conformational Analysis of meso-Ter(1,3-dioxan-4-yls)
Hoffmann, R. W., Mas, G., & Brandl, T. (2002) · European Journal of Organic Chemistry · Cited by 18
Total synthesis of 1-(Z)-atractylodinol
de Oliveira, J. M. G., Zeni, G. R., Malvestiti, I., & Menezes, P. H. (2006) · Tetrahedron Letters · doi:10.1016/j.tetlet.2006.08.130 · Cited by 17
Liu, X., Kong, R., Niu, M., Qiu, R., & Tang, L. (2013) · Journal of Natural Products · doi:10.1021/np300667r · Cited by 13
A Stereoselective Synthesis of the Carbon Backbone of Phoslactomycin B
Raghavan, S., & Patel, J. S. (2017) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201700379 · Cited by 13
Chourreu, P., Guerret, O., Guillonneau, L., Gayon, E., & Lefèvre, G. P. (2021) · European Journal of Organic Chemistry · doi:10.1002/ejoc.202100844 · Cited by 12
Total synthesis of cryptopyranmoscatone B2
Hu, C., Zhao, Z., Nie, P., Du, Y., Feng, F., & Liu, J. (2021) · Tetrahedron · doi:10.1016/j.tet.2021.132609 · Cited by 11
Synthesis of Dehydro-Dephospho-Fostriecin and Formal Total Synthesis of Fostriecin
Gao, D., Li, B., & O'Doherty, G. A. (2019) · Organic Letters · doi:10.1021/acs.orglett.9b03120 · Cited by 10
Li, X., Wang, G., Zhang, Z., Wu, N., Yang, Q., Huang, S., & Wang, X. (2019) · Synthetic Communications · doi:10.1080/00397911.2019.1580373 · Cited by 8
Total and formal syntheses of fostriecin
Dong, G., Li, B., & O'Doherty, G. A. (2020) · Organic Chemistry Frontiers · doi:10.1039/d0qo01121e · Cited by 7
Gu, Q., Kong, L., Yang, L., Zhu, L., & Hong, R. (2020) · Tetrahedron · doi:10.1016/j.tet.2020.131660 · Cited by 6
Formal Synthesis of Fostriecin via Asymmetric Alcohol-Mediated Carbonyl Allylation
Pfaffinger, D. E., & Krische, M. J. (2025) · Organic Letters · doi:10.1021/acs.orglett.5c01026 · Cited by 4
Research works printed but not linked: 3
- Cheng A., 1998, Cancer Res., 58, 3611
- Roberge M., 1994, Cancer Res., 54, 6115
- 10.1002/1099-0690(200210)2002:20<3455::AID-EJOC3455>3.0.CO;2-V · doi:10.1002/1099-0690(200210)2002:20<3455::aid-ejoc3455>3.0.co;2-v
Metadata
- Authors
- Jiang, Y., Yu, X., & Renata, H.
- Affiliations
- Peking University (CN)
- Rice University (US)
- Corresponding author
- Renata, Hans
- Venue
- Journal of the American Chemical Society
- Publisher
- American Chemical Society (ACS)
- Published
- 2025-07-09
- Volume
- 147
- Issue
- 29
- Pages
- 25454-25461
- ISSN
- 0002-7863 (ISSN-L)
- 1520-5126
- PMC
- PMC12490414
- OpenAlex
- W4412119354
- Cited by
- 5
- References
- 50
- Citations by year
- 2026: 4 · 2025: 1
- FWCI
- 1.50
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- Locations
- Journal of the American Chemical Society (publishedVersion)
- ChemRxiv (acceptedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- Funders
- Alfred P. Sloan Foundation
- Cancer Prevention and Research Institute of Texas (RR220087)
- National Institute of General Medical Sciences (R35GM128895)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Enzyme Catalysis and Immobilization
- Physical Sciences › Chemistry › Organic Chemistry › Organophosphorus compounds synthesis
- Physical Sciences › Chemistry › Organic Chemistry › Asymmetric Synthesis and Catalysis
- Keywords
- fostriecin, chemoenzymatic synthesis, late-stage functionalization, protein phosphatase inhibitors, anticancer agents, rational enzyme design, convergent synthesis, natural product synthesis
- MeSH terms
- Enzyme Inhibitors, Molecular Structure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.